Rick E Winningham
Director; Director, CHIEF EXECUTIVE OFFICER · 8 filings · Latest: Sep 23, 2026
Jazz Pharmaceuticals plc
Theravance Biopharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JAZZ | Winningham Rick E | — | Aug 31, 2026 | Proposed Sale | $244.54 | 3,507 | $857.6K | — | |
JAZZ | Rick E Winningham | Director | May 22, 2026 | Sale | $241.57 | 2,741 | $662.1K | 9,567 | |
JAZZ | Rick E Winningham | Director | May 22, 2026 | Option Exercise | $138.08 | 3,415 | $471.5K | 12,308 | |
JAZZ | RICK WINNINGHAM | — | May 22, 2026 | Proposed Sale | $241.57 | 2,741 | $662.1K | — | |
JAZZ | RICK WINNINGHAM | — | Nov 18, 2025 | Proposed Sale | $180.86 | 5,500 | $994.7K | — | |
JAZZ | Winningham Rick E | — | Aug 8, 2025 | Proposed Sale | $112.00 | 3,731 | $417.9K | — |